ZA201102119B - Improved antibody libraies - Google Patents
Improved antibody libraiesInfo
- Publication number
- ZA201102119B ZA201102119B ZA2011/02119A ZA201102119A ZA201102119B ZA 201102119 B ZA201102119 B ZA 201102119B ZA 2011/02119 A ZA2011/02119 A ZA 2011/02119A ZA 201102119 A ZA201102119 A ZA 201102119A ZA 201102119 B ZA201102119 B ZA 201102119B
- Authority
- ZA
- South Africa
- Prior art keywords
- libraies
- improved antibody
- antibody
- improved
- antibody libraies
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B50/00—Methods of creating libraries, e.g. combinatorial synthesis
- C40B50/06—Biochemical methods, e.g. using enzymes or whole viable microorganisms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1018—Orthomyxoviridae, e.g. influenza virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/241—Tumor Necrosis Factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/04—Libraries containing only organic compounds
- C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/04—Libraries containing only organic compounds
- C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof
- C40B40/08—Libraries containing RNA or DNA which encodes proteins, e.g. gene libraries
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
- C12Q2563/185—Nucleic acid dedicated to use as a hidden marker/bar code, e.g. inclusion of nucleic acids to mark art objects or animals
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10148308P | 2008-09-30 | 2008-09-30 | |
| PCT/US2009/059059 WO2010039852A2 (en) | 2008-09-30 | 2009-09-30 | Improved antibody libraries |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA201102119B true ZA201102119B (en) | 2011-12-28 |
Family
ID=42074188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2011/02119A ZA201102119B (en) | 2008-09-30 | 2011-03-22 | Improved antibody libraies |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US8404445B2 (en) |
| EP (1) | EP2340256A4 (en) |
| JP (1) | JP2012504416A (en) |
| KR (1) | KR20110061629A (en) |
| CN (1) | CN102227440A (en) |
| AU (1) | AU2009298501A1 (en) |
| CA (1) | CA2736430A1 (en) |
| IL (1) | IL211552A0 (en) |
| MX (1) | MX2011003380A (en) |
| NZ (1) | NZ591543A (en) |
| RU (1) | RU2011117213A (en) |
| TW (1) | TW201028432A (en) |
| WO (1) | WO2010039852A2 (en) |
| ZA (1) | ZA201102119B (en) |
Families Citing this family (74)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4986370B2 (en) | 2000-12-22 | 2012-07-25 | マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ | Uses of RGM and its modulators |
| CN101277974A (en) * | 2005-09-30 | 2008-10-01 | 阿伯特有限及两合公司 | Binding domains of proteins of the repulsive guidance molecule (RGM) protein family and functional fragments thereof, and their use |
| EP2033971A1 (en) * | 2007-09-06 | 2009-03-11 | Abbott GmbH & Co. KG | Bone Morphogenetic Protein (BMP) binding domains of proteins of the Repulsive Guidance Molecule (RGM) protein family and functional fragments thereof and their application |
| US8962803B2 (en) * | 2008-02-29 | 2015-02-24 | AbbVie Deutschland GmbH & Co. KG | Antibodies against the RGM A protein and uses thereof |
| EP2403531A4 (en) | 2009-03-05 | 2013-02-27 | Abbott Lab | Il-17 binding proteins |
| WO2010127186A1 (en) | 2009-04-30 | 2010-11-04 | Prognosys Biosciences, Inc. | Nucleic acid constructs and methods of use |
| MX336152B (en) | 2009-08-29 | 2016-01-08 | Abbvie Inc | Therapeutic dll4 binding proteins. |
| US9175075B2 (en) * | 2009-12-08 | 2015-11-03 | AbbVie Deutschland GmbH & Co. KG | Methods of treating retinal nerve fiber layer degeneration with monoclonal antibodies against a retinal guidance molecule (RGM) protein |
| NZ602734A (en) | 2010-03-02 | 2014-10-31 | Abbvie Inc | Therapeutic dll4 binding proteins |
| US10787701B2 (en) | 2010-04-05 | 2020-09-29 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
| US20190300945A1 (en) | 2010-04-05 | 2019-10-03 | Prognosys Biosciences, Inc. | Spatially Encoded Biological Assays |
| EP2556171B1 (en) | 2010-04-05 | 2015-09-02 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
| BR122014011544A2 (en) | 2010-05-14 | 2019-08-13 | Abbvie Inc | il-1 binding proteins |
| EP3150750B1 (en) | 2011-04-08 | 2018-12-26 | Prognosys Biosciences, Inc. | Peptide constructs and assay systems |
| GB201106254D0 (en) | 2011-04-13 | 2011-05-25 | Frisen Jonas | Method and product |
| US20230287392A1 (en) * | 2011-04-28 | 2023-09-14 | The Board Of Trustees Of The Leland Stanford Junior University | Identification of Polynucleotides Associated with a Sample |
| SI3415619T1 (en) | 2011-04-28 | 2021-04-30 | The Board of Trustees of the Leland Stanford Junior University Office of the General Counsel Building 170, Third Floor, Main Quad | Identification of polynucleotides associated with a sample |
| EP3318880B1 (en) * | 2011-05-17 | 2020-12-16 | Bristol-Myers Squibb Company | Improved methods for the selection of binding proteins |
| CA2841475C (en) * | 2011-07-12 | 2021-02-09 | Xbiotech Inc. | Identifying affinity-matured human antibodies |
| EP2751291B1 (en) | 2011-09-01 | 2018-08-15 | University of Southern California | Methods for preparing high throughput peptidomimetics, orally bioavailable drugs and compositions containing same |
| IL297229A (en) | 2012-01-27 | 2022-12-01 | Abbvie Inc | Composition and method for diagnosis and treatment of diseases associated with neurite degeneration |
| UY34905A (en) | 2012-07-12 | 2014-01-31 | Abbvie Inc | IL-1 UNION PROTEINS |
| UA118441C2 (en) | 2012-10-08 | 2019-01-25 | Протена Біосаєнсиз Лімітед | Antibodies recognizing alpha-synuclein |
| USRE50065E1 (en) | 2012-10-17 | 2024-07-30 | 10X Genomics Sweden Ab | Methods and product for optimising localised or spatial detection of gene expression in a tissue sample |
| CN111233978B (en) | 2013-03-15 | 2024-08-16 | 普罗格诺西斯生物科学公司 | Methods for detecting peptide/MHC/TCR binding |
| US10119134B2 (en) | 2013-03-15 | 2018-11-06 | Abvitro Llc | Single cell bar-coding for antibody discovery |
| CN111662960B (en) | 2013-06-25 | 2024-04-12 | 普罗格诺西斯生物科学公司 | Spatially encoded bioanalytical analysis using microfluidic devices |
| US9951131B2 (en) | 2013-07-12 | 2018-04-24 | Prothena Biosciences Limited | Antibodies that recognize IAPP |
| WO2015004632A1 (en) | 2013-07-12 | 2015-01-15 | Neotope Biosciences Limited | Antibodies that recognize iapp |
| CN105637097A (en) | 2013-08-05 | 2016-06-01 | 特韦斯特生物科学公司 | De novo synthesized gene libraries |
| WO2015070037A2 (en) | 2013-11-08 | 2015-05-14 | Prognosys Biosciences, Inc. | Polynucleotide conjugates and methods for analyte detection |
| CN111304231A (en) * | 2013-12-30 | 2020-06-19 | 库瑞瓦格股份公司 | Artificial nucleic acid molecules |
| CA2944402A1 (en) | 2014-04-08 | 2015-10-15 | Prothena Biosciences Limited | Blood-brain barrier shuttles containing antibodies recognizing alpha-synuclein |
| ES2895750T3 (en) | 2014-09-15 | 2022-02-22 | Abvitro Llc | High-throughput sequencing of nucleotide libraries |
| JP6897952B2 (en) * | 2014-09-16 | 2021-07-07 | 国立大学法人東京海洋大学 | Method for inducing differentiation into germline using undifferentiated germ cells with concentrated engraftment ability |
| KR101694832B1 (en) * | 2014-12-31 | 2017-01-12 | 앱클론(주) | Antibody Libraries and Methods for Preparation of Them |
| WO2016114567A1 (en) * | 2015-01-13 | 2016-07-21 | 이화여자대학교 산학협력단 | Method for preparing novel antibody library and library prepared thereby |
| US20160222377A1 (en) * | 2015-01-29 | 2016-08-04 | Terry T. Takahashi | Method for generating ultra high affinity peptide ligands |
| CA2975852A1 (en) | 2015-02-04 | 2016-08-11 | Twist Bioscience Corporation | Methods and devices for de novo oligonucleic acid assembly |
| EP3277843A2 (en) * | 2015-03-30 | 2018-02-07 | Cellular Research, Inc. | Methods and compositions for combinatorial barcoding |
| ES2955916T3 (en) | 2015-04-10 | 2023-12-11 | Spatial Transcriptomics Ab | Multiplex analysis of biological specimens of spatially distinguished nucleic acids |
| US9981239B2 (en) | 2015-04-21 | 2018-05-29 | Twist Bioscience Corporation | Devices and methods for oligonucleic acid library synthesis |
| US20160312212A1 (en) * | 2015-04-23 | 2016-10-27 | Roche Sequencing Solutions, Inc. | Cow antibody scaffold polypeptide method and composition |
| JP6982362B2 (en) | 2015-09-18 | 2021-12-17 | ツイスト バイオサイエンス コーポレーション | Oligonucleic acid mutant library and its synthesis |
| WO2017053450A1 (en) | 2015-09-22 | 2017-03-30 | Twist Bioscience Corporation | Flexible substrates for nucleic acid synthesis |
| CN108603307A (en) | 2015-12-01 | 2018-09-28 | 特韦斯特生物科学公司 | functionalized surface and its preparation |
| KR20230042703A (en) * | 2016-06-07 | 2023-03-29 | 맥스-델브뤼크-센트럼 퓌어 몰레쿨라레 메디친 | Chimeric antigen receptor and car-t cells that bind bcma |
| WO2018005720A1 (en) * | 2016-06-30 | 2018-01-04 | President And Fellows Of Harvard College | Method of determining the molecular binding between libraries of molecules |
| CN109996876A (en) | 2016-08-22 | 2019-07-09 | 特韦斯特生物科学公司 | The nucleic acid library of de novo formation |
| CN110225972A (en) * | 2016-09-15 | 2019-09-10 | 奥明塔生物技术公司 | Immune group library sequence amplification method and application |
| JP6871364B2 (en) | 2016-09-21 | 2021-05-12 | ツイスト バイオサイエンス コーポレーション | Nucleic acid-based data storage |
| WO2018112426A1 (en) | 2016-12-16 | 2018-06-21 | Twist Bioscience Corporation | Variant libraries of the immunological synapse and synthesis thereof |
| SG11201907713WA (en) | 2017-02-22 | 2019-09-27 | Twist Bioscience Corp | Nucleic acid based data storage |
| EP3595674A4 (en) | 2017-03-15 | 2020-12-16 | Twist Bioscience Corporation | VARIANT LIBRARIES OF THE IMMUNOLOGICAL SYNAPSE AND SYNTHESIS THEREOF |
| US10696965B2 (en) | 2017-06-12 | 2020-06-30 | Twist Bioscience Corporation | Methods for seamless nucleic acid assembly |
| WO2018231864A1 (en) | 2017-06-12 | 2018-12-20 | Twist Bioscience Corporation | Methods for seamless nucleic acid assembly |
| AU2018328847A1 (en) | 2017-09-11 | 2020-04-23 | Twist Bioscience Corporation | GPCR binding proteins and synthesis thereof |
| CA3079613A1 (en) | 2017-10-20 | 2019-04-25 | Twist Bioscience Corporation | Heated nanowells for polynucleotide synthesis |
| KR20230174295A (en) * | 2017-11-20 | 2023-12-27 | 난트바이오 인코포레이티드 | mRNA DISPLAY ANTIBODY LIBRARY AND METHODS |
| SG11202006460SA (en) | 2018-01-04 | 2020-08-28 | Twist Bioscience Corp | Dna-based digital information storage |
| WO2019199945A1 (en) * | 2018-04-10 | 2019-10-17 | Board Of Regents, The University Of Texas System | Dna-barcoded antigen multimers and methods of use thereof |
| WO2019222706A1 (en) | 2018-05-18 | 2019-11-21 | Twist Bioscience Corporation | Polynucleotides, reagents, and methods for nucleic acid hybridization |
| WO2020077017A2 (en) | 2018-10-10 | 2020-04-16 | Augmenta Bioworks, Inc. | Methods for isolating immune binding proteins |
| US11492727B2 (en) | 2019-02-26 | 2022-11-08 | Twist Bioscience Corporation | Variant nucleic acid libraries for GLP1 receptor |
| CA3131691A1 (en) | 2019-02-26 | 2020-09-03 | Twist Bioscience Corporation | Variant nucleic acid libraries for antibody optimization |
| WO2020205426A1 (en) * | 2019-03-29 | 2020-10-08 | The Regents Of The University Of California | Comprehensive identification of interacting protein targets using mrna display of uniform libraries |
| CN114729342A (en) | 2019-06-21 | 2022-07-08 | 特韦斯特生物科学公司 | Barcode-Based Nucleic Acid Sequence Assembly |
| CA3155630A1 (en) | 2019-09-23 | 2021-04-01 | Twist Bioscience Corporation | Variant nucleic acid libraries for single domain antibodies |
| WO2021061829A1 (en) | 2019-09-23 | 2021-04-01 | Twist Bioscience Corporation | Variant nucleic acid libraries for crth2 |
| WO2021222316A2 (en) | 2020-04-27 | 2021-11-04 | Twist Bioscience Corporation | Variant nucleic acid libraries for coronavirus |
| US11970697B2 (en) | 2020-10-19 | 2024-04-30 | Twist Bioscience Corporation | Methods of synthesizing oligonucleotides using tethered nucleotides |
| US12202905B2 (en) | 2021-01-21 | 2025-01-21 | Twist Bioscience Corporation | Methods and compositions relating to adenosine receptors |
| EP4314075A2 (en) | 2021-03-24 | 2024-02-07 | Twist Bioscience Corporation | Variant nucleic acid libraries for cd3 |
| WO2022271884A2 (en) | 2021-06-22 | 2022-12-29 | Twist Bioscience Corporation | Methods and compositions relating to covid antibody epitopes |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0971946B1 (en) | 1997-01-21 | 2006-07-05 | The General Hospital Corporation | Selection of proteins using rna-protein fusions |
| DE69933369D1 (en) * | 1998-04-03 | 2006-11-09 | Compound Therapeutics Inc | Adressierbare protein arrays |
| MX2009005466A (en) | 2006-11-22 | 2009-08-17 | Adnexus A Bristol Myers Sqibb | Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including igf-ir. |
| WO2009114093A2 (en) * | 2008-03-03 | 2009-09-17 | Abbott Laboratories | Methods for transforming yeast |
-
2009
- 2009-09-30 KR KR1020117009192A patent/KR20110061629A/en not_active Application Discontinuation
- 2009-09-30 JP JP2011530180A patent/JP2012504416A/en active Pending
- 2009-09-30 NZ NZ591543A patent/NZ591543A/en not_active IP Right Cessation
- 2009-09-30 EP EP09818451A patent/EP2340256A4/en not_active Withdrawn
- 2009-09-30 WO PCT/US2009/059059 patent/WO2010039852A2/en active Application Filing
- 2009-09-30 MX MX2011003380A patent/MX2011003380A/en active IP Right Grant
- 2009-09-30 RU RU2011117213/10A patent/RU2011117213A/en not_active Application Discontinuation
- 2009-09-30 AU AU2009298501A patent/AU2009298501A1/en not_active Abandoned
- 2009-09-30 TW TW098133249A patent/TW201028432A/en unknown
- 2009-09-30 US US12/570,897 patent/US8404445B2/en not_active Expired - Fee Related
- 2009-09-30 CN CN2009801477246A patent/CN102227440A/en active Pending
- 2009-09-30 CA CA2736430A patent/CA2736430A1/en not_active Abandoned
-
2011
- 2011-03-03 IL IL211552A patent/IL211552A0/en unknown
- 2011-03-22 ZA ZA2011/02119A patent/ZA201102119B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2010039852A2 (en) | 2010-04-08 |
| EP2340256A2 (en) | 2011-07-06 |
| EP2340256A4 (en) | 2012-03-21 |
| WO2010039852A3 (en) | 2010-07-29 |
| JP2012504416A (en) | 2012-02-23 |
| MX2011003380A (en) | 2011-04-21 |
| RU2011117213A (en) | 2012-11-10 |
| US8404445B2 (en) | 2013-03-26 |
| AU2009298501A1 (en) | 2010-04-08 |
| TW201028432A (en) | 2010-08-01 |
| NZ591543A (en) | 2012-11-30 |
| IL211552A0 (en) | 2011-05-31 |
| CA2736430A1 (en) | 2010-04-08 |
| KR20110061629A (en) | 2011-06-09 |
| US20100099103A1 (en) | 2010-04-22 |
| CN102227440A (en) | 2011-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201102119B (en) | Improved antibody libraies | |
| EP2241578A4 (en) | Anti-cldn6 antibody | |
| GB0821100D0 (en) | Antibodies | |
| GB0708002D0 (en) | Antibodies | |
| PT2146745E (en) | Penta-specific antibody | |
| ZA201104545B (en) | Anti-siglec-15 antibody | |
| IL214996A0 (en) | Anti-bcma antibodies | |
| GB0920127D0 (en) | Antibodies | |
| EP2138576A4 (en) | Anti-claudin-4 antibody | |
| PT2374883T (en) | Anti-cd4 antibody | |
| GB0909906D0 (en) | Antibodies | |
| IL210903A0 (en) | Anit-il-12/il-23 antibodies | |
| EP2427496A4 (en) | Anti-vegf-d antibodies | |
| IL205073A0 (en) | Anti-bst2 antibody | |
| ZA201006099B (en) | Anti-tyrp1 antibodies | |
| GB0718737D0 (en) | Antibodies | |
| GB0920324D0 (en) | Antibodies | |
| EP2274332A4 (en) | Anti-tnf antibody | |
| HK1170745A1 (en) | Antibodies against il-17br il-17br | |
| ZA201007976B (en) | Anti-pirb antibodies | |
| GB0818356D0 (en) | Antibodies | |
| EP2499256A4 (en) | Anti-c-mpl antibodies | |
| GB2473934B (en) | Anti-VEEV antibody | |
| GB0911770D0 (en) | Antibody | |
| EP2264071A4 (en) | Antibody having an immune-enhancement function |